Literature DB >> 28216380

A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time.

Luz Maria Vilca1, Aman Verma2, David Buckeridge3, Magda Campins4.   

Abstract

Pregnant women are vaccinated against influenza less frequently than other high-risk groups. To design effective vaccination strategies, we must understand how decisions regarding vaccination may vary by trimester and over vaccination campaigns. We used a Cox model indexed by calendar time to estimate the effect of gestational trimester and other factors on vaccination uptake in a large cohort of pregnant women in Catalonia (Spain) during 2008-09 to 2012-13 influenza vaccination campaigns. We analyzed 247,316 pregnancies. Vaccination coverage was 3.7%, 5.2%, 4.8%, 5.6% and 4.6% from 2008-09 to 2012-13 seasonal vaccination campaigns and 8.3% for the 2009 pandemic vaccination campaign. Pregnant women previously vaccinated had higher uptake than women not previously vaccinated and the hazard ratios (HRs) comparing these 2 groups decreased from 10, the first day of seasonal campaigns, to 1.3 the last day. During the pandemic campaign, HRs decreased over the course of the campaign from 8.6 to 1.9. Women in second and third trimester had higher uptake than women in first trimester, with HR=2.8 and 2.3, respectively, at the start of seasonal campaigns. Influenza vaccination coverage among this cohort of pregnant women was alarmingly low. Our analysis reveals that gestational and calendar time have distinct and interacting effects on vaccination uptake; women in their second trimester and third trimester and previously vaccinated were more prone to be vaccinated, but this effect wanes as the influenza season progresses.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Cox model; Gestational age; Influenza; Mass vaccination; Pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28216380     DOI: 10.1016/j.ypmed.2017.02.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  6 in total

1.  Maternal Care Providers' Barriers Regarding Influenza and Pertussis Vaccination During Pregnancy in Catalonia, Spain.

Authors:  Luz Maria Vilca; Cristina Martínez; Miriam Burballa; Magda Campins
Journal:  Matern Child Health J       Date:  2018-07

2.  Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua.

Authors:  Carmen S Arriola; Nancy Vasconez; Joseph Bresee; Alba María Ropero
Journal:  Vaccine       Date:  2018-05-07       Impact factor: 3.641

3.  Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.

Authors:  Noelia Rodríguez-Blanco; José Tuells; Rafael Vila-Candel; Andreu Nolasco
Journal:  Int J Environ Res Public Health       Date:  2019-02-14       Impact factor: 3.390

4.  Knowledge and Attitudes about the Flu Vaccine among Pregnant Women in the Valencian Community (Spain).

Authors:  Noelia Rodríguez-Blanco; José Tuells
Journal:  Medicina (Kaunas)       Date:  2019-08-11       Impact factor: 2.430

Review 5.  Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain.

Authors:  Théophile Baïssas; Florence Boisnard; Inmaculada Cuesta Esteve; Marta Garcia Sánchez; Christine E Jones; Thierry Rigoine de Fougerolles; Litjen Tan; Olivier Vitoux; Christina Klein
Journal:  BMC Public Health       Date:  2021-11-29       Impact factor: 3.295

6.  Influenza and Pertussis Maternal Vaccination Coverage and Influencing Factors in Spain: A Study Based on Primary Care Records Registry.

Authors:  María Isabel Fernández-Cano; Antonia Arreciado Marañón; Azahara Reyes-Lacalle; Maria Feijoo-Cid; Josep Maria Manresa-Domínguez; Laura Montero-Pons; Rosa Maria Cabedo-Ferreiro; Pere Toran-Monserrat; Gemma Falguera-Puig
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.